Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

STP.168 Clinical Study Protocol Parakeet

NCT06499142 is registered in ClinicalTrials.gov with Neurovision Medical Products Inc as lead sponsor.

NCT NCT06499142
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06499142 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
STP.168 Clinical Study Protocol Parakeet
Lead sponsor
Neurovision Medical Products Inc
Phase
Not applicable
Overall status
Unknown status
Start date
December 18, 2023
Completion date
January 31, 2025
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperparathyroidism, parathyroid dysfunction, parathyroid gland adenoma, parathyroid; anomaly